Anaesthesia and pain, Guidance

Applied filters

Care Setting (4)
- Neonates (2)
- Palliative and End of Life Care (1)
- Primary Care and PCNs (1)
Guidance (102)
- Advanced therapy medicinal products (1)
- Aseptic services (10)
- Intrathecal medicines (10)
- Prescribing (1)
- Safety in Breastfeeding (79)
- Safety in Pregnancy (2)
- Stability in dosette boxes (57)
- Stability outside the fridge (8)
- Switching (3)
Medicine (100)
- Aceclofenac (1)
- Acemetacin (1)
- Adrenaline (1)
- Alfentanil (1)
- Almotriptan (1)
- Aspirin (1)
- Atracurium (1)
- Atropine (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Bupivacaine (2)
- Buprenorphine (3)
- Capsaicin (1)
- Carbamazepine (1)
- Celecoxib (1)
- Ciclosporin (1)
- Cisatracurium (1)
- Clonidine (2)
- Co-codamol (1)
- Co-dydramol (1)
- Codeine (4)
- Dantrolene (1)
- Dexibuprofen (1)
- Dexketoprofen (1)
- Dexmedetomidine (1)
- Diamorphine (2)
- Diazepam (1)
- Diclofenac sodium (1)
- Dihydrocodeine (4)
- Dihydrocodeine + Paracetamol (1)
- Diltiazem (1)
- Dipipanone + Cyclizine (1)
- Edrophonium (1)
- Eletriptan (1)
- Erenumab (1)
- Etodolac (1)
- Etoricoxib (1)
- Fenoprofen (1)
- Fentanyl (3)
- Flurbiprofen (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fremanezumab (1)
- Frovatriptan (1)
- Gabapentin (1)
- Galcanezumab (1)
- Glycopyrronium (1)
- Hydromorphone (3)
- Hyoscine hydrobromide (1)
- Ibuprofen (2)
- Indometacin (1)
- Isoflurane (1)
- Ketamine (1)
- Ketoprofen (1)
- Levobupivacaine (2)
- Lidocaine (2)
- Lithium (1)
- Lithium carbonate (1)
- Lorazepam (1)
- Mefenamic acid (1)
- Meloxicam (1)
- Meptazinol (1)
- Mesalazine (1)
- Methadone (1)
- Methylphenidate (1)
- Midazolam (1)
- Morphine (5)
- Mycophenolate mofetil (1)
- Nabumetone (1)
- Naloxone (1)
- Naproxen (1)
- Naratriptan (1)
- Nefopam (1)
- Neostigmine (1)
- Nifedipine (1)
- Nitrous oxide gas (1)
- Oxycodone (4)
- Pancuronium (1)
- Papaveretum (1)
- Paracetamol (2)
- Paracetamol + Codeine + Buclizine (1)
- Paracetamol + Dihydrocodeine (1)
- Pentazocine (1)
- Pethidine (1)
- Phenobarbital (1)
- Phenol (1)
- Phentolamine (1)
- Phenytoin (1)
- Piroxicam (1)
- Pregabalin (1)
- Primidone (1)
- Propofol (1)
- Rizatriptan (1)
- Rocuronium (1)
- Ropivacaine (1)
- Sulindac (1)
- Sumatriptan (1)
- Suxamethonium (1)
- Tacrolimus (1)
- Tapentadol (2)
- Temazepam (1)
- Tenoxicam (1)
- Tetracaine (1)
- Tiaprofenic acid (1)
- Tiotropium (1)
- Tizanidine (1)
- Tramadol (5)
- Tramadol + Paracetamol (2)
- Ziconotide (1)
- Zolmitriptan (1)
Medicines planning (34)
- New Medicines (16)
  - CCG commissioned new medicines (15)
  - NHS England commissioned new medicines (1)
  - Pre-registration new medicines (UK/EU) (2)
- Patent expiries (26)
Specialty (102)
- Allergy and immunology (1)
- Anaesthesia and pain (102)
- Cancers (1)
- Cardiovascular system disorders (5)
- Ear, nose and throat disorders (2)
- Endocrine system disorders (1)
- Eyes and vision (5)
- Gastrointestinal disorders (6)
- Mental health and illness (35)
- Musculo-skeletal disorders (27)
- Neurological disorders (14)
- Obstetrics and gynaecology (2)
- Respiratory disorders (3)
- Sexual health (1)
- Skin disorders (2)
- Transplantation (1)

Morphine products: information for supporting intrathecal risk assessment

11 August 2022Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Phenol products: information for supporting intrathecal risk assessment

11 August 2022Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ropivacaine products: information for supporting intrathecal risk assessment

11 August 2022Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Lidocaine products: information for supporting intrathecal risk assessment

11 August 2022Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Diamorphine hydrochloride products: information for supporting intrathecal risk assessment

11 August 2022Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydromorphone products: information for supporting intrathecal risk assessment

11 August 2022Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Bupivacaine products: information for supporting intrathecal risk assessment

11 August 2022Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Levobupivacaine products: information for supporting intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ziconotide products: information for supporting intrathecal risk assessment

11 August 2022Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Clonidine products: information for supporting intrathecal risk assessment

11 August 2022Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

SPS - Specialist Pharmacy Service

NHS